IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
Yuichiro TomiokaYou-Na SungRyuichiro SawadaSeung-Mo HongMasayuki AkitaTomoo ItohTetsuo AjikiTakumi FukumotoYoh ZenPublished in: Histopathology (2019)
KRAS mutations do not appear to be associated with a high risk of malignancy in PBM, while IL-33 overexpression may provide a pro-oncogenic microenvironment in the gallbladder mucosa of patients with PBM.